Anne-Marie Mes-Masson

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 38

Top Topics

Squamous Cell Carcinoma

Radical Prostatectomy

Top Venues

Biochemistry and cell biology = Biochimie et biologie cellulaire

This page only lists publications with an associated author ORCID identifier.

Publications

Jorgelindo da Veiga Moreira, Nancy Nleme, Laurent Schwartz, Kim Leclerc-Desaulniers, Euridice Carmona, Anne-Marie Mes-Masson, Mario Jolicoeur
Methylene Blue Metabolic Therapy Restrains In Vivo Ovarian Tumor Growth. Cancers 16 (2) (2024)
Anne-Marie Mes-Masson
The journey from bench to bedside-it takes a science village. Biochemistry and cell biology = Biochimie et biologie cellulaire (2024)
Anne-Marie Mes-Masson
The journey from bench to bedside-it takes a science village. Biochemistry and cell biology = Biochimie et biologie cellulaire 102 (4) (2024)
Jorgelindo da Veiga Moreira, Nancy Nleme, Laurent Schwartz, Kim Leclerc-Desaulniers, Euridice Carmona, Anne-Marie Mes-Masson, Mario Jolicoeur
Methylene Blue Metabolic Therapy Restrains In Vivo Ovarian Tumor Growth. Cancers 16 (2) (2024)
Carolin Margarethe Sauer, James A Hall, Dominique-Laurent Couturier, Thomas Bradley, Anna M Piskorz, Jacob Griffiths, Ashley Swale, Matthew D Eldridge, Philip S Smith, Karen Hosking, Marika A V Reinius, Lena Morrill Gavarró, Anne-Marie Mes-Masson, Darren Ennis, David Millan, Aoisha Hoyle, Iain A McNeish, Mercedes Jimenez-Linan, Filipe Correia Martins, Julia Tischer, Maria Vias, James D Brenton
Molecular landscape and functional characterization of centrosome amplification in ovarian cancer. Nature communications 14 (1) (2023)
Caitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, Timothée Revil, Setor Amuzu, Karine Bedard, Deepak N Subramanian, Eleanor Fewings, Jeffrey P Bruce, Stephenie D Prokopec, Luigi Bouchard, Diane Provencher, William D Foulkes, Zaki El Haffaf, Anne-Marie Mes-Masson, Marc Tischkowitz, Ian G Campbell, Trevor J Pugh, Celia M T Greenwood, Jiannis Ragoussis, Patricia N Tonin
Molecular Genetic Characteristics of FANCI , a Proposed New Ovarian Cancer Predisposing Gene. Genes 14 (2) (2023)
Caitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, Timothée Revil, Setor Amuzu, Karine Bedard, Deepak N Subramanian, Eleanor Fewings, Jeffrey P Bruce, Stephenie D Prokopec, Luigi Bouchard, Diane Provencher, William D Foulkes, Zaki El Haffaf, Anne-Marie Mes-Masson, Marc Tischkowitz, Ian G Campbell, Trevor J Pugh, Celia M T Greenwood, Jiannis Ragoussis, Patricia N Tonin
Molecular Genetic Characteristics of FANCI , a Proposed New Ovarian Cancer Predisposing Gene. Genes 14 (2) (2023)
Dina Dorrigiv, Pierre-Alexandre Goyette, Amélie St-Georges-Robillard, Anne-Marie Mes-Masson, Thomas Gervais
Pixelated Microfluidics for Drug Screening on Tumour Spheroids and Ex Vivo Microdissected Tumour Explants. Cancers 15 (4) (2023)
Dina Dorrigiv, Pierre-Alexandre Goyette, Amélie St-Georges-Robillard, Anne-Marie Mes-Masson, Thomas Gervais
Pixelated Microfluidics for Drug Screening on Tumour Spheroids and Ex Vivo Microdissected Tumour Explants. Cancers 15 (4) (2023)
Caitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, Timothée Revil, Setor Amuzu, Karine Bedard, Deepak N Subramanian, Eleanor Fewings, Jeffrey P Bruce, Stephenie D Prokopec, Luigi Bouchard, Diane Provencher, William D Foulkes, Zaki El Haffaf, Anne-Marie Mes-Masson, Marc Tischkowitz, Ian G Campbell, Trevor J Pugh, Celia M T Greenwood, Jiannis Ragoussis, Patricia N Tonin
Molecular Genetic Characteristics of FANCI , a Proposed New Ovarian Cancer Predisposing Gene. Genes 14 (2) (2023)
Caitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, Timothée Revil, Setor Amuzu, Karine Bedard, Deepak N Subramanian, Eleanor Fewings, Jeffrey P Bruce, Stephenie D Prokopec, Luigi Bouchard, Diane Provencher, William D Foulkes, Zaki El Haffaf, Anne-Marie Mes-Masson, Marc Tischkowitz, Ian G Campbell, Trevor J Pugh, Celia M T Greenwood, Jiannis Ragoussis, Patricia N Tonin
Molecular Genetic Characteristics of FANCI , a Proposed New Ovarian Cancer Predisposing Gene. Genes 14 (2) (2023)
Dina Dorrigiv, Pierre-Alexandre Goyette, Amélie St-Georges-Robillard, Anne-Marie Mes-Masson, Thomas Gervais
Pixelated Microfluidics for Drug Screening on Tumour Spheroids and Ex Vivo Microdissected Tumour Explants. Cancers 15 (4) (2023)
Caitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, Timothée Revil, Setor Amuzu, Karine Bedard, Deepak N Subramanian, Eleanor Fewings, Jeffrey P Bruce, Stephenie D Prokopec, Luigi Bouchard, Diane Provencher, William D Foulkes, Zaki El Haffaf, Anne-Marie Mes-Masson, Marc Tischkowitz, Ian G Campbell, Trevor J Pugh, Celia M T Greenwood, Jiannis Ragoussis, Patricia N Tonin
Molecular Genetic Characteristics of FANCI , a Proposed New Ovarian Cancer Predisposing Gene. Genes 14 (2) (2023)
Dan Moldoveanu, LeeAnn Ramsay, Mathieu Lajoie, Luke Anderson-Trocme, Marine Lingrand, Diana Berry, Lucas J M Perus, Yuhong Wei, Cleber Moraes, Rached Alkallas, Shivshankari Rajkumar, Dongmei Zuo, Matthew Dankner, Eric Hongbo Xu, Nicholas R Bertos, Hamed S Najafabadi, Simon Gravel, Santiago Costantino, Martin J Richer, Amanda W Lund, Sonia V Del Rincon, Alan Spatz, Wilson H Miller, Rahima Jamal, Réjean Lapointe, Anne-Marie Mes-Masson, Simon Turcotte, Kevin Petrecca, Sinziana Dumitra, Ari-Nareg Meguerditchian, Keith Richardson, Francine Tremblay, Beatrice Wang, May Chergui, Marie-Christine Guiot, Kevin Watters, John Stagg, Abdel Razaq Ahmad A Alyasin, Catalin Mihalcioiu, Sarkis Meterissian
Spatially mapping the immune landscape of melanoma using imaging mass cytometry. Science immunology 7 (70) (2022)
Veronique Ouellet, Andrew Erickson, null null, Kathy Wiley, Colm Morrissey, Viktor Berge, Carlos S Moreno, Kristin Austlid Tasken, Dominique Trudel, Lawrence D True, Michael S Lewis, Aud Svindland, Onur Ertunc, Igor Damasceno Vidal, Adeboye O Osunkoya, Tracy Jones, G Steven Bova, Tarja Lamminen, Ariel H Achtman, Mark Buzza, Michelle M Kouspou, Steven A Bigler, Xinchun Zhou, Stephen J Freedland, Anne-Marie Mes-Masson, Isla P Garraway, Bruce J Trock, Pekka Taimen, Fred Saad, Tuomas K Mirtti, Beatrice S Knudsen, Angelo M DeMarzo
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (4) (2022)
Sophie Gilbert, Benjamin Péant, Anne-Marie Mes-Masson, Fred Saad
IKKε Inhibitor Amlexanox Promotes Olaparib Sensitivity through the C/EBP-β-Mediated Transcription of Rad51 in Castrate-Resistant Prostate Cancer. Cancers 14 (15) (2022)
Maxime Cahuzac, Benjamin Péant, Anne-Marie Mes-Masson, Fred Saad
Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired Resistance. Cancers 14 (16) (2022)
Wejdan M Alenezi, Larissa Milano, Caitlin T Fierheller, Corinne Serruya, Timothée Revil, Kathleen K Oros, Supriya Behl, Suzanna L Arcand, Porangana Nayar, Dan Spiegelman, Simon Gravel, Anne-Marie Mes-Masson, Diane Provencher, William D Foulkes, Zaki El Haffaf, Guy Rouleau, Luigi Bouchard, Celia M T Greenwood, Jean-Yves Masson, Jiannis Ragoussis, Patricia N Tonin
The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population. Cancers 14 (9) (2022)
Charles Dariane, Sylvie Clairefond, Benjamin Péant, Laudine Communal, Zhe Thian, Veronique Ouellet, Dominique Trudel, Nazim Benzerdjeb, Feryel Azzi, Arnaud Méjean, Marc-Olivier Timsit, Manon Baurès, Jacques-Emmanuel Guidotti, Vincent Goffin, Pierre I Karakiewicz, Anne-Marie Mes-Masson, Fred Saad
High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality. Cancers 14 (7) (2022)
Sophie Gilbert, Benjamin Péant, Nicolas Malaquin, Véronique Tu, Hubert Fleury, Kim Leclerc-Desaulniers, Francis Rodier, Anne-Marie Mes-Masson, Fred Saad
Targeting IKKε in Androgen-Independent Prostate Cancer Causes Phenotypic Senescence and Genomic Instability. Molecular cancer therapeutics 21 (3) (2022)
Jean-Philippe Guégan, Marjorie Lapouge, Laure Voisin, Marc K Saba-El-Leil, Pierre-Luc Tanguay, Kim Lévesque, Jérémy Brégeon, Anne-Marie Mes-Masson, Daniel Lamarre, Benjamin Haibe-Kains, Vincent Quoc-Huy Trinh, Geneviève Soucy, Marc Bilodeau, Sylvain Meloche
Signaling by the tyrosine kinase Yes promotes liver cancer development. Science signaling 15 (717) (2022)
Wejdan M Alenezi, Caitlin T Fierheller, Timothée Revil, Corinne Serruya, Anne-Marie Mes-Masson, William D Foulkes, Diane Provencher, Zaki El Haffaf, Jiannis Ragoussis, Patricia N Tonin
Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants. Genes 13 (4) (2022)
Maxime Cahuzac, Patricia Langlois, Benjamin Péant, Hubert Fleury, Anne-Marie Mes-Masson, Fred Saad
Pre-activation of autophagy impacts response to olaparib in prostate cancer cells. Communications biology 5 (1) (2022)
Karen Geoffroy, Patrick Laplante, Sylvie Clairefond, Feryel Azzi, Dominique Trudel, Jean-Baptiste Lattouf, John Stagg, Fred Saad, Anne-Marie Mes-Masson, Marie-Claude Bourgeois-Daigneault, Jean-François Cailhier
High Levels of MFG-E8 Confer a Good Prognosis in Prostate and Renal Cancer Patients. Cancers 14 (11) (2022)
Meshach Asare-Werehene, Hideaki Tsuyoshi, Huilin Zhang, Reza Salehi, Chia-Yu Chang, Euridice Carmona, Clifford L Librach, Anne-Marie Mes-Masson, Chia-Ching Chang, Dylan Burger, Yoshio Yoshida, Benjamin K Tsang
Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes. Cancers 14 (4) (2022)
Laudine Communal, Noemi Roy, Maxime Cahuzac, Kurosh Rahimi, Martin Köbel, Diane M Provencher, Anne-Marie Mes-Masson
A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis. International journal of molecular sciences 22 (10) (2021)
Sylvie Clairefond, Veronique Ouellet, Benjamin Péant, Veronique Lambert, Pierre I Karakiewicz, Anne-Marie Mes-Masson, Fred Saad
Expression of ERBB Family Members as Predictive Markers of Prostate Cancer Progression and Mortality. Cancers 13 (7) (2021)
Zied Boudhraa, Kossay Zaoui, Hubert Fleury, Maxime Cahuzac, Sophie Gilbert, Guergana Tchakarska, Jennifer Kendall-Dupont, Euridice Carmona, Diane Provencher, Anne-Marie Mes-Masson
NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer. Oncogene (2021)
Setor Amuzu, Euridice Carmona, Anne-Marie Mes-Masson, Celia M T Greenwood, Patricia N Tonin, Jiannis Ragoussis
Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines. Cancers 13 (6) (2021)
Chae Young Han, David A Patten, Se Ik Kim, Jung Jin Lim, David W Chan, Michelle K Y Siu, Youngjin Han, Euridice Carmona, Robin J Parks, Cheol Lee, Li-Jun Di, Zhen Lu, Karen K L Chan, Ja-Lok Ku, Elizabeth A Macdonald, Barbara C Vanderhyden, Anne-Marie Mes-Masson, Hextan Y S Ngan, Annie N Y Cheung, Yong-Sang Song, Robert C Bast, Mary-Ellen Harper, Benjamin K Tsang
Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer. Cancers 13 (14) (2021)
Mohamed Amine Lounis, Veronique Ouellet, Benjamin Péant, Christine Caron, Zhenhong Li, Anfal Al-Mass, Sri Ramachandra Murthy Madiraju, Anne-Marie Mes-Masson, Marc Prentki, Fred Saad
Elevated Expression of Glycerol-3-Phosphate Phosphatase as a Biomarker of Poor Prognosis and Aggressive Prostate Cancer. Cancers 13 (6) (2021)
Skye Alexandre Sauriol, Kayla Simeone, Lise Portelance, Liliane Meunier, Kim Leclerc-Desaulniers, Manon de Ladurantaye, Meriem Chergui, Jennifer Kendall-Dupont, Kurosh Rahimi, Euridice Carmona, Diane M Provencher, Anne-Marie Mes-Masson
Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease. Cancers 12 (8) (2020)
Mohamed Amine Lounis, Benjamin Péant, Kim Leclerc-Desaulniers, Dwaipayan Ganguli, Caroline Daneault, Matthieu Ruiz, Amina Zoubeidi, Anne-Marie Mes-Masson, Fred Saad
Modulation of de Novo Lipogenesis Improves Response to Enzalutamide Treatment in Prostate Cancer. Cancers 12 (11) (2020)
Bishnubrata Patra, Muhammad Abdul Lateef, Melica Nourmoussavi Brodeur, Hubert Fleury, Euridice Carmona, Benjamin Péant, Diane Provencher, Anne-Marie Mes-Masson, Thomas Gervais
Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems. PloS one 15 (12) (2020)
Sylvie Clairefond, Benjamin Péant, Veronique Ouellet, Véronique Barrès, Zhe Tian, Dominique Trudel, Pierre I Karakiewicz, Anne-Marie Mes-Masson, Fred Saad
PUMA and NOXA Expression in Tumor-Associated Benign Prostatic Epithelial Cells Are Predictive of Prostate Cancer Biochemical Recurrence. Cancers 12 (11) (2020)
Andrée-Anne Grosset, Veronique Ouellet, Christine Caron, Gabriela Fragoso, Véronique Barrès, Nathalie Delvoye, Mathieu Latour, Armen Aprikian, Alain Bergeron, Simone Chevalier, Ladan Fazli, Neil Fleshner, Martin E Gleave, Pierre Karakiewicz, Louis Lacombe, Jean-Baptiste Lattouf, Theodorus van der Kwast, Dominique Trudel, Anne-Marie Mes-Masson, Fred Saad, null null
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network. PLoS medicine 16 (7) (2019)
Meshach Asare-Werehene, Laudine Communal, Euridice Carmona, Tien Le, Diane Provencher, Anne-Marie Mes-Masson, Benjamin K Tsang
Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer. Scientific reports 9 (1) (2019)
Cécile Le Page, Kurosh Rahimi, Martin Köbel, Patricia N Tonin, Liliane Meunier, Lise Portelance, Monique Bernard, Brad H Nelson, Marcus Q Bernardini, John M S Bartlett, Dimcho Bachvarov, Walter H Gotlieb, Blake Gilks, Jessica N McAlpine, Mark W Nachtigal, Alain Piché, Peter H Watson, Barbara Vanderhyden, David G Huntsman, Diane M Provencher, Anne-Marie Mes-Masson
Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers. BMC cancer 18 (1) (2018)